The current analyst and expert consensus on VBI Vaccines is Strong Buy with 0 strong sell and 2 strong buy opinions. The current projected target price consensus is 8.5 with 2 analysts opinions. The most common way VBI Vaccines Inc analysists use to provide recommendation to public is financial statements analysis. Many experts also interview VBI Vaccines executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on VBI Vaccines. We encourage you to use your own analysis of VBI Vaccines Inc to validate this buy or sell advice. VBI Vaccines buy or sell recommendation module provides average expert sentiment on the projected VBI Vaccines Inc target price to derive its highest and lowest estimates based on projected price volatility of 2.121. Also please take a look at Macroaxis Advice on VBI Vaccines to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.